Apollomics (APLM) Total Non-Current Liabilities (2021 - 2025)
Apollomics (APLM) reported Total Non-Current Liabilities of $3.6 million for Q4 2025, up 1183.64% quarter-over-quarter from -$330000.0 in Q4 2023.
Apollomics (APLM) Total Non-Current Liabilities (2021 - 2025) Analysis & Trends
Apollomics (APLM) has 4 years of Total Non-Current Liabilities data on file, last reported at $3.6 million in Q4 2025.
- Total Non-Current Liabilities for Q4 2025 came in at $3.6 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $3.6 million (changed N/A YoY), and the FY2025 annual result was $3.6 million, up 3605.88% from the prior year.
- Total Non-Current Liabilities rose to $3.6 million in Q4 2025 per APLM's latest filing, from -$330000.0 in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $512.2 million in Q4 2022 and troughed at -$330000.0 in Q4 2023.
- A 4-year average of $168.0 million and a median of $3.6 million in 2025 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities surged 58.71% in 2022, then plunged 100.06% in 2023.
- A 4-year view of Total Non-Current Liabilities shows it stood at $322.7 million in 2021, then jumped by 58.71% to $512.2 million in 2022, then sank by 100.06% to -$330000.0 in 2023, then jumped by 1183.64% to $3.6 million in 2025.
- Business Quant data shows APLM's Total Non-Current Liabilities at $3.6 million in Q4 2025, -$330000.0 in Q4 2023, and $1.5 million in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 42,980.09 |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 11.03 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 95.20 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 5.87 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 64.76 Mn |
| 10 | Apollomics | 294.00 Mn | 294.00 Mn | - | 3.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.58 Mn |
| Dec 31, 2023 | -330,000.00 |
| Jun 30, 2023 | 1.55 Mn |
| Dec 31, 2022 | 512.24 Mn |
| Dec 31, 2021 | 322.74 Mn |